Introduction
============

*Bacillus megaterium*, an aerobic bacterium ubiquitous in a diverse range of environments, has been of special investigative interest for its applications in promoting plant health ([@B10]; [@B24]), bioremediation of contaminants ([@B21]), and industrial bioproduction ([@B28]; [@B29]; [@B4]). Despite extensive genetic characterization of *B. megaterium*, detailed elucidation of its metabolic network is still lacking ([@B15]; [@B10]; [@B14]). Much of what is known about carbon metabolism in *Bacillus* species is derived from *Bacillus subtilis*, the primary model organism for Gram-positive bacteria ([@B26]; [@B8]; [@B7]; [@B11]). Previous metabolic studies highlighted incongruent metabolic fluxes between *B. subtilis* and *B. megaterium* species ([@B26]; [@B8]; [@B7]; [@B11]; [@B12],[@B13]; [@B27]; [@B33]). Metabolic flux modeling has been performed on mutant strains of *B. megaterium* that lacked specific metabolic functions ([@B13]). Therefore, the operational network of wild-type *B. megaterium* remains to be evaluated experimentally. Of particular interest is an investigation of the different catabolic routes that initiate carbohydrate metabolism in *B. megaterium* due to the ubiquitous presence of carbohydrate-containing feedstocks.

Here, we investigated the metabolic fluxes underlying the catabolism of glucose, fructose, and xylose in *B*. *megaterium* QM B1551. Glucose, a monomer of the biopolymers cellulose and starch, is a common carbohydrate in environmental matrices ([@B16]). The disaccharide sucrose, a dimer with glucose and fructose, is common in plant materials and can serve as a carbon source to *B. megaterium* ([@B33]). Xylose, a pentose monosaccharide, is a major monomer in hemicellulose, an abundant component of plant cell walls ([@B16]). The enzymes involved in the uptake pathway of all three carbohydrates (i.e., glucose, fructose, and xylose) have been annotated in the genome of *B. megaterium* (Figure [1](#F1){ref-type="fig"}). The metabolic pathways that can be involved in carbohydrate catabolism are the Embden--Meyerhof--Parnas (EMP) pathway, the gluconate pathway, the oxidative pentose--phosphate (PP) pathway, the non-oxidative PP pathway, and the Entner--Doudoroff (ED) pathway (Figure [1](#F1){ref-type="fig"}).

![Schematic of metabolic pathways involved in glucose, fructose, and xylose catabolism in *B. megaterium* QM B1551. The following pathways are emphasized: gluconate pathway (in red), the Entner--Doudoroff (ED) pathway (in blue), the Embden--Meyerhof--Parnas (EMP) pathway (in light green), the pentose--phosphate (PP) pathway (in black), the fructose uptake pathway (in dark green), and the xylose uptake pathway (in orange). The gene annotated corresponding to each metabolic enzyme is placed next to the respective reaction arrow. The information for the network was compiled from the KEGG database ([@B15]; [@B14]) and MetaCyc database ([@B5]). The metabolite abbreviations are as follows: GDL, glucono-1,5-lactone; G6P, glucose-6-phosphate; 6-PGL, 6-phosphogluconolactone; 6P-gluconate, 6-phosphogluconate; KDPG, 2-keto-3-deoxy-6-phosphogluconate; Ru5P, ribulose 5-phosphate; Xu5P, xylulose 5-phosphate; S7P, sedoheptulose 7-phosphate; E4P, erythrose 4-phosphate; F6P, fructose 6-phosphate; FBP, fructose 1,6-bisphosphate; DHAP, dihydroxyacetone-3-phosphate; GAP, glyceraldehyde 3-phosphate; 1,3-bisPG, 1,3-biphosphoglycerate; 3PG, 3-phosphoglycerate; 2PG, 2-phosphoglycerate; PEP, phosphoenolpyruvate. The enzymes corresponding to the gene annotations are as follows: *amyD*, carbohydrate ABC transporter permease AmyD; *ptsG*, PTS system glucose-specific transporter subunit IIBC; *ptsH*, phosphocarrier protein HPr; *ptsI*, PTS system transporter I; *gdh*, glucose 1-dehydrogenase; *pgi*, glucose-6-phosphate isomerase; *gntK*, gluconate kinase; *BMQ_1157*, fructokinase; *xylT*, xylose permease; *xylA*, [D]{.smallcaps}-xylose isomerase; *xylB*, xylokinase; *BMQ_0309*, 6-phosphogluconolactonase; *BMQ_3633*, 2-dehydro-3-deoxyphosphogluconate aldolase; *fruA*, PTS system fructose-specific II subunit IIA; *fruB*, PTS system fructose-specific II subunit IIB; *zwf*, glucose-6-phosphate 1-dehydrogenase; *gntZ*, phosphogluconate dehydrogenase; *rpe*, ribulose-phosphate 3-epimerase; *rpiA*, ribose 5-phosphate isomerase A; *tkt*, transketolase; *tal*, transaldolase; *pfk*, 6-phosphofructokinase; *fbp*, fructose-1,6-bisphosphatase; *fba*, fructose-1,6-bisphosphate aldolase; *tpiA*, triosephosphate isomerase; *gap*, glyceraldehyde-3-phosphate dehydrogenase; *pgk*, phosphoglycerate kinase; *pgm*, phosphoglucomutase; *eno*, enolase; *pgy*, pyruvate kinase.](fmicb-09-02789-g001){#F1}

It is well established that *Bacillus* species undergo glycolysis *via* the EMP pathway wherein glucose is first phosphorylated to glucose-6-phosphate (G6P), then isomerized to fructose-6-phosphate (F6P) before phosphorylation to fructose-1,6-bisphosphate (FBP) (Figure [1](#F1){ref-type="fig"}). An important step that provides the driving force for the yields of ATP downstream of the EMP pathway is the lysis of FBP to dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (GAP) (Figure [1](#F1){ref-type="fig"}; [@B22]). The metabolites in the EMP pathway can also contribute to the PP pathway (Figure [1](#F1){ref-type="fig"}). The oxidative phase of the PP pathway involves the oxidation of G6P to 6-phosphogluconate (6P-gluconate) followed by decarboxylation to PPs; the non-oxidative phase involves the transketolase and transaldolase reactions that combine F6P and GAP to yield intermediates in the PP pathway \[xylulose-5-phosphate (Xu5P), erythrose-4-phosphate (E4P), and sedoheptulose-7-phosphate (S7P)\] (Figure [1](#F1){ref-type="fig"}). Carbon fluxes from the EMP and PP pathways, which are eventually channeled to the tricarboxylic acid (TCA) cycle, generate reducing equivalents \[NAD(P)H\], energy (ATP), and metabolite precursors for biomass growth (i.e., biosynthesis of ribonucleotides for RNA and DNA, biosynthesis of amino acids for proteins) (Figure [1](#F1){ref-type="fig"}).

There is a lack of consensus regarding the distribution of the flux from G6P to the EMP pathway relative to the flux from G6P to the PP pathway *via* 6P-gluconate ([@B26]; [@B7]; [@B12],[@B13]; [@B27]). Certain strains of *B. subtilis* (PRF93) were reported to utilize the PP pathway more than the direct EMP pathway ([@B26]), whereas the opposite was reported for other *B. subtilis* strains (wild-type strain 168 and mutant strains RB50::\[pRF69\]~n~,) ([@B7]; [@B27]). In one mutant strain of *B. megaterium* (WH323), carbon starvation was shown to promote usage of the EMP pathway over the PP pathway, whereas recombinant gene induction increased activity in the PP pathway relative to the EMP pathway ([@B12],[@B13]). Furthermore, only a forward flux of the EMP pathway has been portrayed in previous models of *Bacillus* species, including *B. megaterium* ([@B26]; [@B7]; [@B13]; [@B27]). However, the genome of *B. megaterium* QM B1551 annotates the enzymes that can operate both forward and backward fluxes through the EMP pathway ([@B15]; [@B14]; Figure [1](#F1){ref-type="fig"}). The contribution of both of these fluxes, which has implications for the net thermodynamic driver of the EMP pathway, has been unexplored in previous *Bacillus* studies ([@B26]; [@B7]; [@B12],[@B13]; [@B27]).

Regarding the gluconate pathway, which involves the oxidation of glucose to gluconate followed by phosphorylation to 6P-gluconate (Figure [1](#F1){ref-type="fig"}), annotation of the *B. megaterium* QM B1551 genome implied an incomplete gluconate pathway ([@B15]; [@B14]). Specifically annotated in the genome were glucose-1-dehydrogenase and gluconate kinase, which convert glucose to glucono-1,5-lactone and gluconate to 6P-gluconate, respectively (Figure [1](#F1){ref-type="fig"}; [@B15]; [@B14]). However, the enzyme gluconolactonase for the hydrolysis of glucono-1,5-lactone to gluconate was not present, albeit this reaction can happen spontaneously in highly alkaline conditions (Figure [1](#F1){ref-type="fig"}; [@B15]; [@B14]). Interestingly, despite the lack of genome annotation of gluconolactonase, evidence of the gluconate pathway was found in germinating spores of *B. megaterium* QM B1551 wherein significant gluconate evolution from glucose was detected ([@B20]; [@B23]). The connection between the gluconate pathway and the remaining network for carbohydrate catabolism in *B. megaterium* remains unclear. *Pseudomonas* species, which are well known to exhibit the gluconate pathway, rely significantly on the ED pathway to connect the gluconate pathway to downstream metabolism ([@B9]; [@B19]; [@B25]; [@B32]). Due to the absence of all the relevant enzymes, a functional ED pathway in *Bacillus* species has not been considered in previous metabolic studies ([@B12],[@B13]; [@B27]). Specifically, in *B. megaterium* QM B1551, genome-level characterization has annotated one of the two essential enzymes required for the ED pathway ([@B15]; [@B14]) (Figure [1](#F1){ref-type="fig"}). This characterization has noted the presence of 2-keto-3-deoxyphosphogluconate aldolase but the upstream enzyme, 6-phosphogluconate dehydratase, is absent from the genome of *B. megaterium* QM B1551 (Figure [1](#F1){ref-type="fig"}). Both the gluconate pathway and the ED pathway have not been considered in previously reported metabolic network models of *Bacillus* species ([@B26]; [@B7]; [@B12],[@B13]; [@B27]; [@B17]).

Previous metabolic flux analysis (MFA) of *Bacillus* species has relied on ^13^C-labeled amino acid labeling to estimate labeling at specific metabolic nodes ([@B26]; [@B7]; [@B12],[@B13]; [@B27]; [@B17]). However, because there are only two amino acid precursors from intermediates in the PP pathway \[ribose-5-phosphate (R5P) and E4P\], this method is not suitable for high-resolution determination of the carbon fluxes through the PP pathway as well as the other vicinal metabolic pathways such as the gluconate pathway and the ED pathway. Furthermore, labeling of free metabolites is needed for more accurate quantitative determination of flux distribution between the EMP pathway and the adjacent pathways. Here, we employed a ^13^C-assisted metabolomic approach using high-resolution liquid chromatography--mass spectrometry (LC--MS) to detect free metabolites involved in all four pathways. We obtained both kinetic and long-term ^13^C labeling of intracellular metabolites. We combined the cellular ^13^C mapping with growth phenotypes to perform quantitative flux analysis of carbohydrate catabolism. Our results provide new insights on the metabolic network structure and flux distribution in *B. megaterium* (strain QM B1551). These findings have broader implications regarding the optimization of *Bacillus* and related bacterial species in biotechnological applications.

Experimental Methods
====================

Culturing Conditions
--------------------

The *B. megaterium* QM B1551 cells were obtained from the Bacillus Genetic Stock Center (Columbus, OH, United States). Cell cultures were grown at 30°C in a G24 environmental incubator shaker (New Brunswick Scientific, Edison, NJ, United States) at 220 rpm. The growth medium, which was pH-adjusted (pH 7.0) and filter-sterilized (0.22 μm nylon; Waters Corporation, MA, United States), contained the following major salts: 18.7 mM NH~4~Cl, 0.81 mM MgSO~4~, 0.034 mM CaCl~2~. 2H~2~O, 89.4 mM K~2~HPO~4~, 56.4 mM NaH~2~PO~4~.H~2~O, 8.6 mM NaCl. The trace metal concentrations were as follows: 30 μM FeSO~4~.7H~2~O, 1.9 μM H~3~BO~3~, 0.86 μM CuSO~4~.5H~2~O, 7.7 μM ZnSO~4~.7H~2~O, 0.75 μM MnSO~4~.H~2~O, 0.26 μM NiCl~2~.6H~2~O, and 0.31 μM Na~2~MoO~4~.2H~2~O. The carbohydrate composition was 330 mM C total as glucose alone (equivalent to 55 mM or 9.91 g L^-1^ glucose), fructose, alone, xylose alone, 1:1 glucose:gluconate mixture, or equimolar glucose:fructose:xylose mixture. All chemicals listed above were analytical grade, purchased from Sigma-Aldrich (St. Louis, MO, United States) and Fisher Scientific (Pittsburg, PA, United States). For all growth conditions, the cells were transferred twice into fresh growth media to ensure that the cells were well acclimated to their nutrient growth conditions prior to experimental sampling. Cell growth (three biological replicates per condition) was monitored *via* both optical density at 600 nm (OD~600~) using an Agilent Cary UV-visible spectrophotometer (Santa Clara, CA, United States) and measuring cell dry weight (in grams, gCDW). To obtain accurate reading at OD~600~ above 0.5, cell suspensions were diluted. To determine the cell dry weight (three biological replicates), we centrifuged (9,391 *g* for 5 min at 4°C) harvested 1.5-mL culture aliquots and the retentate was frozen (-20°C) overnight prior to lyophilization using a Labconco freeze-dryer (Kansas City, MO, United States). The conversion factors of g~CDW~ L^-1^ per OD~600~ were found to be: 0.61 ± 0.08 for glucose; 0.43 ± 0.10 for glucose:fructose:xylose; and 0.53 ± 0.07 for glucose:gluconate.

Carbohydrate Consumption
------------------------

The depletion of substrate in the extracellular medium was taken to account for sugar consumption; this was confirmed by intracellular ^13^C labeling ([@B2]). To quantify substrate depletion by exponentially growing cells under each growth condition, 0.7 mL aliquots were harvested at different times (two independent biological replicates at each timepoint) throughout cell growth and analyzed *via* ^1^H nuclear magnetic resonance (NMR). The extracted aliquots were centrifuged for 30 min at 15,871 *g* and 4°C in filter-containing (0.22-μm pore size, nylon) microcentrifuge tubes. The filtered supernatants were frozen at -20°C until further processing. In preparation for the NMR analysis, 200 μL of the filtered samples were mixed with 60 μL of 100% D~2~O, 50 μL of 6 mM 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) as an internal standard, 240 μL of 100 mM sodium bicarbonate as a pH control, and 50 μL of 10 mM sodium-azide as an antimicrobial agent. Samples were stored at 4°C until analysis ([@B2]). The ^1^H NMR measurements were performed using a Varian Unity INOVA 600-MHz NMR spectrometer at 25°C, with a relaxation delay of 5 s, recording of 16 scans per sample, and receiver gain of 32 dB ([@B2]). Substrate depletion rates (in mmol gCDW^-1^ h^-1^) were determined subsequently *via* regression analysis of carbohydrate depletion over time combined with biomass growth rate.

Metabolite Excretion
--------------------

To determine excretion rates of metabolites, 50 μL of filtered cell suspensions (three biological replicates per condition) were obtained during growth and subsequently diluted with LC--MS grade water (Fisher Scientific, Pittsburgh, PA, United States) at 1:20 v/v during early exponential phase, or 1:200 v/v during late exponential and stationary phases. Different dilution ratios were used to account for elevated concentrations of extracellular metabolites in the media as a function of cell growth. The samples were stored at 4°C (for 5 h or less) prior to processing *via* LC--MS. Excretion rates (μmol gCDW^-1^ h^-1^) were calculated *via* regression analysis.

Kinetic Metabolite ^13^C Labeling
---------------------------------

Kinetic flux experiments were performed to monitor *in vivo* cellular incorporation of glucose ([@B25]). Batch cultures (two independent biological replicates) were grown as described above for the glucose-growth condition until early exponential phase, corresponding to OD~600~ 0.4--0.6. Aliquots (3 mL) of the cultures were filtered (0.22-μm nylon filter). Each cell-containing filter disk was then placed cell-side up on an agar plate containing unlabeled carbon in minimal media to allow the cells to acclimate and reach an exponentially growing phase, corresponding to OD~600~ 0.5. To determine when this OD~600~ value was reached, cells on filters from parallel plates were rinsed off into a 3-mL suspension for OD~600~ reading. After the cells were adequately acclimated on the agar plate, the cell-containing filter disks were transferred to agar plates containing \[U-^13^C~6~\]-glucose and, after a set period of time following the isotopic switch (0 and 20 s; 1, 4, 12, and 30 min), the filter disks were removed from the labeled plate and metabolism was immediately quenched by flipping the disks cell-side down into a 2-mL cold (4° C) methanol:acetonitrile:water quenching solution (2:2:1). The quenched solution containing the lysed cells scraped from the filter disks was then centrifuged (5 min at 9,391 *g* and 4°C). We dried 100-μL aliquots of the supernatants under N~2~ gas prior to re-suspension in 100-μL LC--MS water for use in metabolomics analysis as described below.

Long-Term Intracellular Metabolite ^13^C Labeling
-------------------------------------------------

For long-term isotopic enrichment of the intracellular metabolites, liquid cultures were prepared with the growth medium containing the major and minor salts as listed above and the following ^13^C-labeled substrates: \[1,2-^13^C~6~\]-glucose alone, equimolar \[U-^13^C~6~\]-glucose and unlabeled gluconate, or equimolar \[1,2,3-^13^C~3~\]-glucose, \[1,6-^13^C~2~\]-fructose, and unlabeled xylose. All labeled carbohydrates were purchased from Cambridge Isotopes (Tewksbury, MA, United States) or Omicron Biochemicals (South Bend, IN, United States). For these labeling experiments, batch cultures (two independent biological replicates) were grown twice in labeled minimal media and sampling was done at two timepoints (when the cells reached OD~600~ of 1.0 and 2.0) during exponential growth (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). At each sampling time, 3 mL aliquots of cell suspensions were filtered through 0.22-μm nylon filters in a sterile environment. The cell-containing filter disks were immediately quenched in 2 mL of cold (4°C) methanol:acetonitrile:water solution (2:2:1). The lysed cells in the quenching solution were processed as described in the previous section in preparation for metabolomics analysis as described below.

Metabolomics Analysis *via* LC--MS
----------------------------------

The samples prepared as described above were analyzed by reversed-phase ion-pairing ultra-high performance LC (Thermo Scientific Dionex UltiMate 3000) coupled to high-resolution/accurate MS (Thermo Scientific Q Exactive quadrupole-Orbitrap hybrid MS) with electrospray ionization run in full-scan negative mode ([@B3]). Details of the LC--MS protocol used here were previously reported ([@B3]). The following metabolites were isolated by LC--MS: gluconate, 6P-gluconate, G6P, F6P, FBP, pyruvate, Xu5P, R5P, DHAP, and S7P. As previously detailed and illustrated in [@B1], the analytical isolation of the different compound isomers (i.e., G6P/F6P, Xu5P/R5P, and DHAP/GAP) was made possible due to their chromatographic separations, despite their similar mass-over-charge ratios. Metabolite standards at various concentrations (10--1,000 nM) were also run in parallel to verify LC--MS identification and quantitation. The ^13^C labeling patterns were analyzed with the MAVEN (Metabolomic Analysis and Visualization Engine) software suite ([@B18]; [@B6]). The labeling data were corrected subsequently for natural abundance of ^13^C.

Quantitative Metabolic Flux Analysis
------------------------------------

The MFA of *B. megaterium* cells grown on glucose alone or the glucose:fructose:xylose mixture was constrained by the following experimental data: substrate consumption rates, metabolite excretion rates, long-term ^13^C labeling data of intracellular metabolites, and biomass growth. We employed previously reported stoichiometric biomass composition for *B. subtilis* ([@B8]) to estimate metabolite effluxes (from G6P, R5P, E4P, 3-PG, pyruvate, and DHAP) to sustain the biomass requirements for cell growth under each condition. The modeling software suite 13CFLUX2 was used to conduct the MFA analysis of the pathway network involving metabolic nodes for substrate uptake, the gluconate pathway, the EMP pathway, the PP pathway, and the biomass effluxes ([@B30]). Metabolite secretion rates were also included for gluconate. The model was initialized using a number of free fluxes, informed by previous values of fluxes in *B. megaterium* ([@B12]). From these free fluxes, which were unconstrained values assigned by the user to provide an initial set of flux values, the modeling algorithm optimized all flux values in accordance with the experimental constraints through an iterative process (Supplementary Tables [S1](#SM1){ref-type="supplementary-material"}, [S2](#SM1){ref-type="supplementary-material"}). At each iteration, the quality of estimated fluxes was evaluated by calculating residual errors between the model-estimated metabolite labeling data and the corresponding experimental data (Supplementary Figures [S2](#SM1){ref-type="supplementary-material"}, [S3](#SM1){ref-type="supplementary-material"}).

Results
=======

Glucose Catabolism Involves the Gluconate Pathway Without the ED Pathway
------------------------------------------------------------------------

Following uptake of extracellular glucose, glucose catabolism can be initiated by either phosphorylation to G6P or oxidation to gluconate (Figure [1](#F1){ref-type="fig"}). Kinetic ^13^C-labeling data following feeding of cells on \[U-^13^C~6~\]-glucose showed, by 30 min, nearly complete isotopic enrichment of G6P and 6P-gluconate and ∼75% isotopic enrichment of gluconate (Figure [2A](#F2){ref-type="fig"}). The ^13^C labeling of gluconate was indicative of glucose oxidation to gluconate, which was also reported in spores of *B. megaterium* QM B1551 ([@B20]; [@B23]). The plateau of gluconate ^13^C labeling below 100% may be due to carry over of residual non-labeled gluconate in the extracellular milieu because gluconate secretion was evident during growth of *B. megaterium* on glucose alone (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Evidence of the gluconate pathway, which would include phosphorylation of gluconate to 6P-gluconate could not be resolved from the kinetic intracellular labeling from ^13^C-glucose alone. The similar labeling kinetics for 6P-gluconate and G6P implied that 6P-gluconate was primarily produced from G6P but these data could not confirm either the presence or lack of gluconate flux to 6P-gluconate (Figure [2A](#F2){ref-type="fig"}). To capture specifically the incorporation of gluconate-derived carbons into 6P-gluconate, we fed the cells equimolar concentrations of fully ^13^C-labeled glucose and unlabeled gluconate (Figure [2B](#F2){ref-type="fig"}). Across the two timepoints during exponential growth on this glucose:gluconate mixture, the fraction of non-labeled 6P-gluconate increased from 18% to 36%, confirming the presence of an active gluconate pathway (Figure [2B](#F2){ref-type="fig"}). However, given the high-fraction of ^13^C-labeled 6P-glcuonate (above 60%), these kinetic data also indicated that the assimilation route of glucose-derived ^13^C carbons from G6P to 6P-gluconate was favored over the gluconate pathway (Figure [2B](#F2){ref-type="fig"}).

![Presence of gluconate pathway and absence of Entner--Doudoroff pathway. **(A)** Kinetic ^13^C profiling of G6P, 6P-gluconate, and gluconate in cells grown on fully ^13^C-labeled glucose. **(B)** Carbon mapping and long-term intracellular ^13^C labeling at two timepoints during growth on fully ^13^C-labeled glucose and unlabeled gluconate (OD~600~ = 1, T1; OD~600~ = 2, T2). The ED pathway is marked with a cross. **(C)** Ratio of metabolite levels in cells grown on glucose alone versus cells grown on both glucose and gluconate. Measured data (average ± data range) were from two technical replicates of two independent biological replicates for each timepoint. Growth curves in Supplementary Figure [S1](#SM1){ref-type="supplementary-material"} indicate when data were acquired during biomass growth. Definitions for metabolite abbreviations are as shown in Figure [1](#F1){ref-type="fig"} caption.](fmicb-09-02789-g002){#F2}

There are two possible fates of 6P-gluconate: the oxidative PP pathway and the ED pathway (Figure [2B](#F2){ref-type="fig"}). The ED pathway involves the splitting of 6P-gluconate into GAP and pyruvate (Figure [2B](#F2){ref-type="fig"}). At the timepoint when 6P-gluconate had the highest non-labeled fraction (∼36%), the non-labeled fractions of both pyruvate and DHAP (an isomer of GAP) were less than 5% (i.e., within the error range of the LC--MS detection) (Figure [2B](#F2){ref-type="fig"}). The oxidative PP pathway was expected to generate non-labeled PPs (such as R5P) as evidence of catabolism of gluconate-derived carbons *via* this pathway (Figure [2B](#F2){ref-type="fig"}). We found that nearly 20% of R5P was non-labeled, implying that about 72% of the R5P pool was synthesized from 6P-gluconate *via* the oxidative PP pathway (Figure [2B](#F2){ref-type="fig"}). Therefore, these data collectively demonstrated that the fate of 6P-gluconate was through the oxidative PP pathway and that the ED pathway was inactive in *B. megaterium* QM B1551.

We compared the metabolite pools in cells grown on the equimolar glucose:gluconate mixture to those in cells grown on glucose alone -- the total substrate carbon concentration (330 mM C) was the same in both conditions (Figure [2C](#F2){ref-type="fig"}). There was no appreciable change in the levels of G6P and F6P (Figure [2C](#F2){ref-type="fig"}). However, during growth on the glucose:gluconate mixture, the level of 6P-gluconate was severely depleted (16-fold reduction), in agreement with limited flux from gluconate to 6P-gluconate, as indicated by the labeling data (Figures [2B,C](#F2){ref-type="fig"}). In accordance with the lack of the ED pathway, we obtained a decrease in both DHAP (∼3-fold reduction) and pyruvate (∼30-fold reduction) during feeding on the glucose:gluconate mixture (Figure [2C](#F2){ref-type="fig"}). Interestingly, despite the depletion in DHAP, which is downstream of FBP, there was an accumulation in FBP (∼18-fold increase) during feeding on the glucose:gluconate mixture (Figure [2C](#F2){ref-type="fig"}). Given the constant level of F6P upstream of FBP, these data implied that, when gluconate is present with glucose, the flux of FBP production from F6P exceeded the flux of FBP lysis to generate DHAP and GAP (Figure [2C](#F2){ref-type="fig"}).

Glucose Catabolism to Pyruvate Is Through a Partially Reversible EMP Pathway
----------------------------------------------------------------------------

Following the ^13^C probing approach described above, \[1,2-^13^C~2~\]-glucose was chosen as a substrate to evaluate possible backward fluxes in the EMP pathway (Figure [3](#F3){ref-type="fig"}). These backward fluxes, which are implied from the annotated genome of *B. megaterium* ([@B15]; [@B14]), have not been probed previously. The forward EMP pathway involves carbon flux from glucose through G6P, F6P, FBP, and onward to DHAP and GAP following FBP lysis (Figure [3](#F3){ref-type="fig"}). In agreement with the assimilation of the doubly ^13^C-labeled glucose, we obtained ∼90% doubly ^13^C-labeled fractions for gluconate, 6P-gluconate, G6P, and F6P (Figure [3](#F3){ref-type="fig"}). However, there was a discrepancy between the labeling patterns of F6P and those of FBP (Figure [3](#F3){ref-type="fig"}). Compared to F6P, there was a 30% depletion in the doubly ^13^C-labeled fraction of FBP (Figure [3](#F3){ref-type="fig"}). Moreover, non-labeled FBP was 10%, compared to 1% in F6P; the quadruply ^13^C-labeled fraction was 14% in FBP, compared to 2% in F6P (Figure [3](#F3){ref-type="fig"}). Non-labeled intermediates in the EMP pathway were generated during lysis of the doubly \[1,2-^13^C~2~\]-FBP into \[2,3-^13^C~2~\] DHAP and non-labeled GAP (Figure [3](#F3){ref-type="fig"}). Equilibrium isotopic labeling between the isomers DHAP and GAP led to the measurement of near equal fraction (∼50%) of non-labeled and doubly ^13^C-labeled fractions in DHAP (Figure [3](#F3){ref-type="fig"}). Operating the EMP pathway in the reverse direction by combining the labeling scheme for DHAP and GAP to produce FBP explained the non-labeled and quadruply ^13^C-labeled fraction in FBP, in addition to the doubly ^13^C-labeled fraction (Figure [3](#F3){ref-type="fig"}). However, the fact that F6P was primarily doubly ^13^C-labeled indicated that the EMP pathway was only partially reversible (Figure [3](#F3){ref-type="fig"}).

![Partial reversibility of the Embden--Meyerhof--Parnas pathway. Carbon mapping (left) and metabolite labeling (right) in the gluconate pathway and the EMP pathway following feeding on \[1,2-^13^C~2~\]-glucose. The red colored arrows and carbon skeletons are to illustrate the formation of metabolites from backward flux in the upper EMP pathway. Measured data (average ± data range) were collected at two different timepoints during cell growth (T1, OD~600~ = 1.0; T2, OD~600~ = 2.0) from two technical replicates of two independent biological replicates at each timepoint. Growth curves in Supplementary Figure [S1](#SM1){ref-type="supplementary-material"} indicate when data were acquired during biomass growth. Definitions for metabolite abbreviations are as shown in Figure [1](#F1){ref-type="fig"} caption.](fmicb-09-02789-g003){#F3}

Glucose Catabolism and Gluconate Pathway Are Both Connected to a Primarily Oxidative PP Pathway
-----------------------------------------------------------------------------------------------

The PP pathway possesses both an oxidative route and a non-oxidative route (Figures [4A,B](#F4){ref-type="fig"}). The oxidative PP pathway involves the decarboxylation of 6P-gluconate to Ru5P, which subsequently interconverts to R5P and Xu5P; the non-oxidative PP pathway combines metabolites from the EMP pathway, F6P and GAP, to generate eventually Xu5P and R5P (Figures [4A,B](#F4){ref-type="fig"}). According to our labeling scheme, decarboxylation of doubly ^13^C-labeled 6P-gluconate through the oxidative PP pathway would produce singly ^13^C-labeled R5P and Xu5P but the non-oxidative PP pathway would use EMP-pathway metabolites to generate triply ^13^C-labeled R5P and Xu5P (Figures [4A,B](#F4){ref-type="fig"}). We found that the metabolite labeling patterns of R5P and Xu5P were primarily singly ^13^C-labeled (77 and 72%, respectively) and only up to 18% of these metabolites were triply ^13^C-labeled (Figure [4](#F4){ref-type="fig"}); in accordance with the labeling of Xu5P and R5P, we also obtained primarily doubly ^13^C-labeled S7P (Figure [4](#F4){ref-type="fig"}). Thus, the labeling patterns of Xu5P and R5P were consistent with a significant involvement of the oxidative PP pathway with relatively minor contribution from the non-oxidative pathway (Figure [4](#F4){ref-type="fig"}). Therefore, through the oxidative PP pathway, PP metabolites were primarily produced from 6P-gluconate, which was generated from both the gluconate pathway and the direct glucose catabolism through G6P.

![Predominance of the oxidative pentose phosphate (PP) pathway over the non-oxidative PP pathway. Carbon mapping **(A,B)** and metabolite labeling **(C)** in the PP pathway following feeding on \[1,2-^13^C~2~\]-glucose. Carbon mapping is shown for carbon flow from the oxidative PP pathway **(A)** or from the metabolites in the EMP pathway incorporated into the non-oxidative PP pathway **(B)**. Blue-colored circles and arrows indicate metabolite labeling patterns derived from the EMP pathway operating in the direction of the non-oxidative PP pathway. Measured data (average ± data range) were collected at two different timepoints (T1, OD~600~ = 1.0; T2, OD~600~ = 2.0) from two technical replicates of two independent biological replicates. Growth curves in Supplementary Figure [S1](#SM1){ref-type="supplementary-material"} indicate when data were acquired during biomass growth. Definitions for metabolite abbreviations are as shown in Figure [1](#F1){ref-type="fig"} caption.](fmicb-09-02789-g004){#F4}

Simultaneous Processing of Different Carbohydrates Is Partitioned Into Different Catabolic Routes
-------------------------------------------------------------------------------------------------

Previous reports of carbon metabolism and metabolic flux modeling have focused on glucose-grown *Bacillus* species ([@B26]; [@B7]; [@B27]). However, glucose is often present with other carbohydrates in carbon feedstocks ([@B31]). In addition to glucose, we were able to obtain growth of the *B. megaterium* cells when the sole carbon source was given as fructose (another common hexose) or xylose (a common pentose) (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). These data thus indicated that, in accordance with the genome annotation (Figure [1](#F1){ref-type="fig"}), the cells have the transporters and catabolic pathways to assimilate these carbohydrates. We also investigated how *B. megaterium* QM B1551 processes simultaneously glucose, fructose, and xylose by monitoring intracellular incorporation of equimolar carbon-equivalent concentrations of \[1,2,3-^13^C~3~\]-glucose, \[1,6-^13^C~2~\]-fructose, and unlabeled xylose (Figure [5](#F5){ref-type="fig"}). The labeling data revealed that a non-uniform intracellular routing of each substrate in the metabolic network (Figure [5](#F5){ref-type="fig"}).

![Non-uniform incorporation of carbohydrate mixture into metabolism. Carbon mapping (left) and metabolite labeling (right) following feeding on \[1,2,3-^13^C~3~\]-glucose (black circles), \[1,6-^13^C~2~\]-fructose (blue circles), and unlabeled xylose (red circles). The red-colored arrows and carbon skeletons are to illustrate the formation of metabolites that are a result of the partially reversible Embden--Meyerhof--Parnas (EMP) pathway or backward flux from EMP pathway to the non-oxidative pentose--phosphate pathway. Measured data (average ± data range) were collected at two different timepoints during cell growth (T1, OD~600~ = 1.0; T2, OD~600~ = 2.0). Growth curves in Supplementary Figure [S1](#SM1){ref-type="supplementary-material"} indicate when data were acquired during biomass growth. Definitions for metabolite abbreviations are as shown in Figure [1](#F1){ref-type="fig"} caption.](fmicb-09-02789-g005){#F5}

Consistent with the oxidation of the triply ^13^C-labeled glucose, gluconate was predominantly triply ^13^C-labeled (at ∼85%) (Figure [5](#F5){ref-type="fig"}). From the phosphorylation of triply ^13^C-labeled glucose to G6P, the G6P pool had a high triply ^13^C-labeled fraction (60--73%) with a lesser amount of doubly ^13^C-labeled (19%) fraction (Figure [5](#F5){ref-type="fig"}). Downstream of G6P and gluconate, 6P-gluconate was ∼85% triply ^13^C-labeled and 11% doubly ^13^C-labeled (Figure [5](#F5){ref-type="fig"}). The enrichment in triply ^13^C-labeled fraction (by up to 20%) from G6P to 6P-gluconate emphasized the contribution of gluconate to generate 6P-gluconate, thus underscoring an active gluconate pathway in initiating the catabolism of glucose-derived carbons during growth on multiple carbohydrates (Figure [5](#F5){ref-type="fig"}). The small fraction of doubly ^13^C-labeled fractions in both G6P and 6P-gluconate reflected the minor incorporation of fructose-derived carbons in these metabolites (Figure [5](#F5){ref-type="fig"}).

Notably, for the F6P pool, we obtained an equal amount (∼45% each) of triply ^13^C-labeled fraction and doubly ^13^C-labeled fractions, respectively from glucose-derived and fructose-derived carbons (Figure [5](#F5){ref-type="fig"}). Forward flux through the EMP pathway was expected to generate ^13^C labeling for FBP similar to F6P and, subsequently, the splitting of the triply ^13^C-labeled and doubly ^13^C-labeled fractions of FBP would generate equal proportions of non-labeled, singly ^13^C-labeled, and triply ^13^C-labeled fractions of triose-phosphates (Figure [5](#F5){ref-type="fig"}). In accordance with this labeling scheme in the EMP pathway, we did obtain an equal proportion of non-labeled, singly ^13^C-labeled and triply ^13^C-labeled fractions of DHAP, 3-PG, and pyruvate (Figure [5](#F5){ref-type="fig"}). However, in addition to doubly and triply ^13^C-labeled FBP (at 20--32%), there were other ^13^C-labeled fractions in FBP (at 5-15%) (Figure [5](#F5){ref-type="fig"}). Specifically, the latter fractions were non-labeled, singly ^13^C-labeled, quadruply ^13^C-labeled, and sextuply ^13^C-labeled fractions of FBP (Figure [5](#F5){ref-type="fig"}). Thus, the labeling pattern of FBP reflected backward flux from the combination of DHAP and GAP to produce FBP (Figure [5](#F5){ref-type="fig"}). However, this backward flux was not extended to F6P (Figure [5](#F5){ref-type="fig"}). Therefore, the partial reversibility of carbon flux in the upper EMP pathway previously discussed with the glucose-grown cells was also evident in cells grown on the glucose:fructose:xylose mixture (Figures [3](#F3){ref-type="fig"}, [5](#F5){ref-type="fig"}). It is important to note that, in addition to indicating that the upper EMP pathway was only partially reversible, the distinct difference between the labeling patterns of F6P and FBP revealed that F6P was the entry point for the catabolism of fructose-derived carbons (Figure [5](#F5){ref-type="fig"}).

With respect to xylose assimilation, the incorporation of xylose-derived carbons was expected to introduce non-labeled carbons in the PP pathway. However, non-labeled fractions in the PP pathway metabolites (R5P, Xu5P, and S7P) were only 5% or less (Figure [5](#F5){ref-type="fig"}). By contrast, in accordance with the oxidative PP pathway, triply ^13^C-labeled 6P-gluconate from assimilated glucose-derived carbons led to 52--60% doubly ^13^C-labeled fractions in both R5P and Xu5P (Figure [5](#F5){ref-type="fig"}). Consistent with the combination of these latter two metabolites to produce S7P, we obtained quadruply ^13^C-labeled S7P (∼46%) (Figure [5](#F5){ref-type="fig"}). Despite the predominance of the oxidative PP pathway, minor fractions of other ^13^C isotopologs of the PP pathway metabolites were consistent with minor flux of the non-oxidative PP pathway (Figure [5](#F5){ref-type="fig"}). In sum, during growth on the carbohydrate mixture, glucose-derived carbons primarily populated the gluconate pathway and the oxidative PP pathway, both fructose-derived and glucose-derived carbons equally contributed to the EMP pathway, and the assimilation of xylose was insignificant (Figure [5](#F5){ref-type="fig"}).

Quantitative Flux Modeling During Growth on Glucose Alone Versus a Mixture With Glucose, Fructose, and Xylose
-------------------------------------------------------------------------------------------------------------

Using the ^13^C labeling data and the growth phenotypes, we performed MFA to quantitate explicitly up to 18 fluxes through the different catabolic routes for carbohydrate utilization in *B. megaterium* during growth on glucose alone or with fructose and xylose (Figure [6](#F6){ref-type="fig"}). The fluxes were normalized to the glucose uptake rate in both growth conditions (Figure [6](#F6){ref-type="fig"}) -- the absolute fluxes are presented in Supplementary Table [S2](#SM1){ref-type="supplementary-material"}. The cellular fluxes demonstrated that different catabolic routes were accentuated in *B. megaterium* depending on whether the cells were processing a single or a mixture of carbohydrate substrates (Figure [6](#F6){ref-type="fig"}).

![Cellular metabolic flux distributions. Metabolic flux analysis of *B. megaterium* QM B1551 during feeding on **(A)** \[1,2-^13^C~2~\]-glucose or **(B)** a mixture of \[1,2,3-^13^C~3~\]-glucose, \[1,6-^13^C~2~\]-fructose, and unlabeled xylose. All fluxes were normalized to 100% glucose uptake and the thickness of each arrow was scaled to this flux percentage. Fluxes toward biomass production are shown in red. Gluconate excretion is shown in blue. Flux values (average ± data range) were generated using experimental data from two independent biological replicates, at OD~600~ = 2. Growth curves in Supplementary Figure [S1](#SM1){ref-type="supplementary-material"} indicate when data were acquired during biomass growth. Definitions for metabolite abbreviations are as shown in Figure [1](#F1){ref-type="fig"} caption.](fmicb-09-02789-g006){#F6}

Compared to the metabolism of glucose alone, there was a two-fold increase of the flux through the gluconate pathway in cells grown on the mixture (Figures [6A,B](#F6){ref-type="fig"}). This increased flux through the gluconate pathway during processing of the mixture was accompanied by a decrease (by up to 12%) in the carbon flux from G6P to F6P (Figures [6A,B](#F6){ref-type="fig"}). The increased carbon flux through the gluconate pathway led to a 17% increase in the activity of the oxidative PP pathway, from 6P-gluconate to Ru5P, in cells grown on the mixture relative to glucose alone (Figures [6A,B](#F6){ref-type="fig"}). Subsequent fluxes through the PP pathway were also increased (Figures [6A,B](#F6){ref-type="fig"}). The exception was the increase (by 25%) in the reaction flux that combines Xu5P and E4P to produce F6P and GAP (Figures [6A,B](#F6){ref-type="fig"}), which may be influenced by the influx of fructose-derived carbons into the EMP pathway (Figures [5](#F5){ref-type="fig"}, [6A,B](#F6){ref-type="fig"}). During growth on the mixture, the uptake flux from fructose to F6P was about half of the glucose uptake flux (Figure [6B](#F6){ref-type="fig"}). The second annotated pathway for fructose uptake (i.e., from fructose to FBP), was found to be inactive (Figures [1](#F1){ref-type="fig"}, [6B](#F6){ref-type="fig"}). Due to the incorporation of fructose-derived carbons at the metabolic node of F6P, the flux through the remaining EMP pathway downstream of F6P, was increased by up to 70% (Figures [6A,B](#F6){ref-type="fig"}). Thus, the overall flux profile in the gluconate pathway, EMP pathway, and PP pathway was reprogrammed to accommodate the assimilation of fructose (Figures [6A,B](#F6){ref-type="fig"}).

Discussion
==========

Here, we employed ^13^C-carbon mapping of intracellular metabolism to address knowledge gaps regarding the routes for carbohydrate catabolism in *B. megaterium* QM B1551. We also resolved inconsistencies from previous studies on *Bacillus* species regarding the relative flux from glucose catabolism through either the EMP pathway or the PP pathway ([@B26]; [@B7]; [@B12],[@B13]; [@B27]; [@B17]). Our ^13^C labeling data presented evidence of both glucose oxidation to gluconate and flux from gluconate to 6P-gluconate, thus confirming the presence of the complete gluconate pathway in *B. megaterium* (Figures [2A,B](#F2){ref-type="fig"}). Our data also revealed that flux through the gluconate pathway was compromised by congestion at the gluconate node (Figures [2A,B](#F2){ref-type="fig"}). Further studies are needed to elucidate the regulatory mechanism for the gluconate pathway in *B. megaterium* QM B1551, which was beyond the scope of our data. Interestingly, in *Pseudomonas* species, gluconate pathway is strongly linked to a very active ED pathway ([@B19]; [@B25]; [@B32]). Although the ED pathway was widely neglected in prior MFAs conducted on *Bacillus* species ([@B12],[@B13]; [@B27]), genomic characterization of *B. megaterium* QM B1551 annotated one of the two essential enzymes in the ED pathway (Figure [1](#F1){ref-type="fig"}; [@B15]; [@B14]). However, our data demonstrated that the ED pathway was not active in *B. megaterium* QM B1551 (Figure [2B](#F2){ref-type="fig"}). Regarding the traditional glycolytic pathway (i.e., the EMP pathway), our flux modeling determined a net forward flux through the EMP pathway (Figure [6](#F6){ref-type="fig"}), in agreement with previous MFA studies on *Bacillus* species including *B. megaterium* ([@B26]; [@B7]; [@B12],[@B13]; [@B27]). However, our discrete metabolite labeling data revealed that the FBP lysis was reversible (Figures [3](#F3){ref-type="fig"}, [5](#F5){ref-type="fig"}). The consequence of this reversibility regarding the optimization of bioproduct generation in *B. megaterium* species remains to be determined.

The resolution of metabolite labeling in the PP pathway of *Bacillus* species has previously been deduced from ^13^C labeling of their amino acid derivatives ([@B26]; [@B7]; [@B13]; [@B17]). Here, using a LC--MS approach to obtain the labeling patterns of three free metabolites specific to the PP pathway, we determined that the flux through the oxidative PP pathway (i.e., from 6P-gluconate to Ru5P) was ∼6-fold to ∼10-fold greater than the flux through the non-oxidative PP pathway (from F6P and GAP) (Figures [4C](#F4){ref-type="fig"}, [6B](#F6){ref-type="fig"}). This relative contribution of the two routes in the PP pathway was larger than previous published estimates, which reported a 3.5- to 5-fold greater activity of the oxidative PP pathway activity than non-oxidative PP pathway in *Bacillus* species ([@B26]; [@B7]; [@B13]). The increased flux through the oxidative PP pathway determined from our modeling fluxes implied that the *B. megaterium* QM B1551 cells can afford a greater production of reducing power through the generation of NADPH than previously estimated.

While glucose is the substrate of choice to elucidate the metabolism of most bacterial model systems, a mixture of carbohydrates is typically present in environmental systems or in engineered bioreactors for industrial applications ([@B31]). Biomass growth on only glucose, fructose, or mannose indicated that *B. megaterium* can rely on each substrate as a sole source of carbon in its metabolism (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). However, our metabolic study of cells fed on equimolar carbon-equivalent concentrations of glucose, fructose, and xylose revealed that *B. megaterium* QM B1551 utilizes different catabolic routes to process this carbohydrate mixture (Figures [5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}). No appreciable incorporation of xylose-derived carbons was detected (Figure [5](#F5){ref-type="fig"}). Carbons derived from fructose and glucose contributed equally to the flux in the EMP pathway from F6P to the triose phosphates (Figure [5](#F5){ref-type="fig"}). The gluconate pathway was only populated by glucose-derived carbons (Figure [5](#F5){ref-type="fig"}). Flux of glucose-derived carbons was also significant from the gluconate pathway through the oxidative PP pathway (Figures [5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}). Our findings thus demonstrated that *B. megaterium* QM B1551 grown on a mixture can exhibit both complete repression of a given carbohydrate assimilation and preferential channeling of the assimilated carbohydrates into different catabolic routes. These findings have important implications for the processing of different carbon feedstocks. Follow-up metabolic flux studies and proteomics profiling are needed to gain further insights on how *B. megaterium* regulates this hierarchy in carbohydrate catabolism in response to different composition and concentration of carbohydrate mixtures.

Given the emergent usage of different feedstocks in engineered bioproduction, it is critical to understand the metabolic network in biotechnologically important bacterial species in response to various carbon sources ([@B31]). Due to the abundance of carbohydrate-containing feedstocks, we have focused here on determining the flux through the different catabolic pathways available for carbohydrate processing in *B. megaterium* QM B1551. The ^13^C-metabolomics approaches employed here present a powerful tool to elucidate new pathways and gain insights on existing pathways involved in the intracellular network of cellular metabolism. These approaches could be instrumental to the broader field of metabolic characterization of environmentally-relevant bacteria and optimization of bacterial cells in biotechnological applications.
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